Rein Therapeutics (RNTX) Other Non Operating Income (2019 - 2026)
Rein Therapeutics (RNTX) recorded Other Non Operating Income of $461,000 in Q2 2026, up 668.3% from $60,000 a year earlier.
Powered by 
Analysis
Rein Therapeutics (RNTX) Other Non Operating Income (2019 - 2026) Analysis & Trends
On a TTM basis, Rein Therapeutics' Other Non Operating Income came in at -$256,000 as of Jun 30, 2026; for FY2025, it came in at $48,000, down 93.0% from FY2024.
- Across earlier years, Other Non Operating Income came in at $685,000 in FY2024 (+25.9%), $544,000 in FY2023 (+71.1%), $318,000 in FY2022 (-27.9%) and $441,000 in FY2021.
- The Q2 2026 figure is the highest quarterly Other Non Operating Income in data going back to Q1 2019.
- On a year-over-year basis, Other Non Operating Income rose in three of the last four quarters, with growth averaging 172.8%.
- Peak year-over-year performance for Other Non Operating Income in the last five years was growth of 668.3% in Q2 2026, against a decline of 93.9% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -$608,000 (Q1 2026), -$20,000 (Q4 2025) and -$89,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Rein Therapeutics | 53.67 Mn | 53.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 461,000.00 |
| Mar 31, 2026 | -608,000.00 |
| Dec 31, 2025 | -20,000.00 |
| Sep 30, 2025 | -89,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 108,000.00 |
| Dec 31, 2024 | 272,000.00 |
| Sep 30, 2024 | 224,000.00 |
| Jun 30, 2024 | 97,000.00 |
| Mar 31, 2024 | 92,000.00 |
| Dec 31, 2023 | -49,000.00 |
| Sep 30, 2023 | 156,000.00 |
| Jun 30, 2023 | 205,000.00 |
| Mar 31, 2023 | 232,000.00 |
| Dec 31, 2022 | 336,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Mar 31, 2022 | -22,000.00 |
| Dec 31, 2021 | 71,000.00 |
| Sep 30, 2021 | 66,000.00 |
| Jun 30, 2021 | 304,000.00 |
API Access
Rein Therapeutics Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=RNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "RNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=RNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();